• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Slides for the September 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee

 

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance
 
 
FDA
 
FDA Core Presentations, MERIDIA (Sibutramine Hydrochloride Monohydrate), for the September 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee:
 
Eric Colman, M.D., Deputy Director, Division of Metabolism and Endocrinology Products (DMEP), Office of Drug Evaluation (ODE) II, Office of New Drugs (OND), CDER, FDA - Morning Slides (PDF - 52KB)
 
Vicky Borders-Hemphill, Pharm.D. CDR, Division of Epidemiology (DEPI), Office of Surveillance and Epidemiology (OSE), CDER, FDA (PDF - 87KB)
 
Simone P. Pinheiro, Sc.D., M.Sc., DEPI, OSE, CDER, FDA (PDF - 86KB)
 
Jo Wyeth, Pharm.D., Division of Pharmacovigilance (DPV) I, OSE, CDER, FDA (PDF - 39KB)
 
Joyce Weaver, Pharm.D., Division of Risk Management (DRISK), OSE, CDER, FDA (PDF - 64KB)
 
Monique Falconer, M.D., DMEP, ODE II, OND, CDER, FDA (PDF - 752KB)
 
Eric Colman, M.D., Deputy Director, DMEP, ODE II, OND, CDER, FDA Afternoon Slides (PDF – 1.08MB)
 
 
Sponsor
 
Abbott Laboratories Core Presentation, MERIDIA (Sibutramine Hydrochloride Monohydrate), for the September 15, 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (PDF - 867KB)
 
 
Open Public Hearing Slide Presentations
 
Morgan Downey, J.D., The Downey Obesity Report (PDF – 295KB)
 
Aldo Tinoco, M.D., M.P.H., Public Citizen, presenting on behalf of Sidney Wolfe, M.D., Public Citizen (PDF – 49KB)